Syneos Health, Inc. - (SYNH): Price and Financial Metrics


Syneos Health, Inc. - (SYNH): $51.45

2.21 (+4.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SYNH POWR Grades

  • SYNH scores best on the Growth dimension, with a Growth rank ahead of 98.62% of US stocks.
  • SYNH's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • SYNH's current lowest rank is in the Quality metric (where it is better than 17.31% of US stocks).

SYNH Stock Summary

  • SYNH has a higher market value than 76.72% of US stocks; more precisely, its current market capitalization is $4,888,336,670.
  • With a one year PEG ratio of 60.2, SYNEOS HEALTH INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 71.57% of US stocks.
  • The ratio of debt to operating expenses for SYNEOS HEALTH INC is higher than it is for about 76.72% of US stocks.
  • If you're looking for stocks that are quantitatively similar to SYNEOS HEALTH INC, a group of peers worth examining would be CSSE, RUTH, HCCI, MAXR, and RIBT.
  • SYNH's SEC filings can be seen here. And to visit SYNEOS HEALTH INC's official web site, go to www.syneoshealth.com.

SYNH Valuation Summary

  • In comparison to the median Healthcare stock, SYNH's price/sales ratio is 52.63% lower, now standing at 0.9.
  • SYNH's price/sales ratio has moved down 0.3 over the prior 96 months.

Below are key valuation metrics over time for SYNH.

Stock Date P/S P/B P/E EV/EBIT
SYNH 2022-09-23 0.9 1.5 17.7 18.0
SYNH 2022-09-22 0.9 1.5 17.8 18.0
SYNH 2022-09-21 0.9 1.5 18.0 18.2
SYNH 2022-09-20 0.9 1.5 18.4 18.4
SYNH 2022-09-19 1.0 1.6 18.9 18.7
SYNH 2022-09-16 1.0 1.6 19.0 18.8

SYNH Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 10.41%.
  • Its 3 year net income to common stockholders growth rate is now at 1186.55%.
  • The year over year revenue growth rate now stands at 19.71%.
Over the past 37 months, SYNH's revenue has gone up $872,383,000.

The table below shows SYNH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 5,418.606 405.272 278.122
2022-03-31 5,340.478 394.077 242.283
2021-12-31 5,212.97 450.278 234.831
2021-09-30 4,979.605 378.625 250.758
2021-06-30 4,730.379 486.123 235.931
2021-03-31 4,461.167 591.188 197.937

SYNH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SYNH has a Quality Grade of D, ranking ahead of 21.57% of graded US stocks.
  • SYNH's asset turnover comes in at 0.618 -- ranking 262nd of 563 Business Services stocks.
  • INS, HURN, and MEDP are the stocks whose asset turnover ratios are most correlated with SYNH.

The table below shows SYNH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.618 0.233 0.100
2021-06-30 0.602 0.238 0.096
2021-03-31 0.579 0.234 0.085
2020-12-31 0.580 0.230 0.083
2020-09-30 0.602 0.225 0.067
2020-06-30 0.612 0.218 0.070

SYNH Price Target

For more insight on analysts targets of SYNH, see our SYNH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $80.92 Average Broker Recommendation 1.33 (Strong Buy)

SYNH Stock Price Chart Interactive Chart >

Price chart for SYNH

SYNH Price/Volume Stats

Current price $51.45 52-week high $104.18
Prev. close $49.24 52-week low $46.24
Day low $50.20 Volume 750,393
Day high $51.83 Avg. volume 690,870
50-day MA $61.30 Dividend yield N/A
200-day MA $75.08 Market Cap 5.28B

Syneos Health, Inc. - (SYNH) Company Bio


Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.


SYNH Latest News Stream


Event/Time News Detail
Loading, please wait...

SYNH Latest Social Stream


Loading social stream, please wait...

View Full SYNH Social Stream

Latest SYNH News From Around the Web

Below are the latest news stories about SYNEOS HEALTH INC that investors may wish to consider to help them evaluate SYNH as an investment opportunity.

Here's Why Investors Should Retain Syneos Health (SYNH) for Now

Investors are optimistic about Syneos Health's (SYNH) better-than-expected earnings and robust segmental results.

Yahoo | September 13, 2022

Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | September 7, 2022

Syneos Health to Present at the 2022 Baird Global Healthcare Conference

MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe and Chief Financial Officer Jason Meggs are scheduled to present at the 2022 Baird Global Healthcare Conference on September 13, 2022, at 2:00 p.m. ET. A webcast of the event, along with a link to the presentation materials and archived replay of the presentation, will be available on the

Yahoo | August 30, 2022

Is It Time To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

While Syneos Health, Inc. ( NASDAQ:SYNH ) might not be the most widely known stock at the moment, it received a lot of...

Yahoo | August 8, 2022

Syneos Health (SYNH) Q2 Earnings Top Estimates, Cuts '22 View

Syneos Health (SYNH) posts better-than-expected earnings in the second quarter and robust results across the Clinical Solutions and Commercial Solutions businesses.

Yahoo | August 4, 2022

Read More 'SYNH' Stories Here

SYNH Price Returns

1-mo -11.72%
3-mo -29.14%
6-mo -39.29%
1-year -41.37%
3-year -2.67%
5-year -3.92%
YTD -49.89%
2021 50.71%
2020 14.55%
2019 51.14%
2018 -9.75%
2017 -17.11%

Continue Researching SYNH

Want to see what other sources are saying about Syneos Health Inc's financials and stock price? Try the links below:

Syneos Health Inc (SYNH) Stock Price | Nasdaq
Syneos Health Inc (SYNH) Stock Quote, History and News - Yahoo Finance
Syneos Health Inc (SYNH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5826 seconds.